硝酸铅

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 结构与计算化学
  • 表征图谱

硝酸铅 基本信息

中文名称:
硝酸铅 
中文别名:
硝酸铅;
硝酸鉛 
英文名称:
Lead dinitrate
英文别名:
lead nitrate;
PB(NO3)2;
LeadNitrateAcs;
LeadNitrateAr;
LEAD STANDARD;
Lead(II)nitrate;
plumbousnitrate;
leaddinitrate;
Lead(II) nitrate;
Lead nitrate;
LeadNitrateGr;
nitratedeplomb;
LEAD(+2)NITRATE;
Lead(II) Nitrate;
Enriched Isotope 207Pb Spike;
LEAD NITRATE;
Lead dinitrate 
CAS No.:
10099-74-8
分 子 式:

N2O6Pb

分 子 量:
331.21
精确分子量:
331.95200
PSA:
137.76000
MDL:
MFCD00011153
EINECS:
233-245-9
InChI:
InChI=1/2HNO3.Pb/c2*2-1(3)4;/h2*(H,2,3,4);
危险品标志:

ToxicTDangerousN

风险术语:

R20/22;R33;R50/53

安全术语:
S45;S53;S60
分子结构式:
SDS:
查看

硝酸铅 制备方法及用途

制备方法

1.盐析法 将金属铅放人熔铅炉中熔化后,水激成铅花或制成铅皮,再卷成铅卷。将铅卷(或铅花)放人耐酸反应器中,加入约20%稀硝酸,在稍过量铅的情况下进行反应,至反应液呈淡黄色,溶液浓度约40°Bé为止。澄清后趁热过滤,除去杂质。清液送入盐析器,边搅拌边加人浓硝酸,即有硝酸铅析出,搅拌1~2h后静置,使硝酸铅结晶下沉,经离心分离,制得硝酸铅成品。其反应方程式如下: 2.蒸发法 按盐析法生产过程中得到的硝酸铅溶液,趁热过滤除去杂质,加入硝酸酸化至草绿色,送人蒸发器在常压进行浓缩至59.7°Bé,即有硝酸铅结晶析出,经离心分离,制得硝酸铅成品。其反应方程式如下: 反应过程中有氧化氮气体逸出,有毒,处理方法参见硝酸钠生产的吸收法。3.用80kg洁净的蒸馏水在搅拌、加热条件下溶解60kg工业硝酸铅,待溶液沸腾后加入投料量0.5%的化学纯氨水,待氢氧化铁沉淀生成后,趁热过滤,滤液冷却结晶,过滤,离心甩干,即得试剂硝酸铅。一次结晶不合格,可再行重结晶处理。4.将颗粒状铅溶解于密度为1.40的硝酸中(1kg铅用1250ml硝酸),按反应的速度调节反应温度: 待反应结束后,冷却,硝酸铅即以细小的结晶粉末析出,然后用浓硝酸洗涤,抽滤后按方法3提纯。若采用高纯度铅、硝酸和电导水,可制得高纯硝酸铅。

合成制备方法

1.盐析法 将金属铅放人熔铅炉中熔化后,水激成铅花或制成铅皮,再卷成铅卷。将铅卷(或铅花)放人耐酸反应器中,加入约20%稀硝酸,在稍过量铅的情况下进行反应,至反应液呈淡黄色,溶液浓度约40°Bé为止。澄清后趁热过滤,除去杂质。清液送入盐析器,边搅拌边加人浓硝酸,即有硝酸铅析出,搅拌1~2h后静置,使硝酸铅结晶下沉,经离心分离,制得硝酸铅成品。其反应方程式如下:

2.蒸发法 按盐析法生产过程中得到的硝酸铅溶液,趁热过滤除去杂质,加入硝酸酸化至草绿色,送人蒸发器在常压进行浓缩至59.7°Bé,即有硝酸铅结晶析出,经离心分离,制得硝酸铅成品。其反应方程式如下:

反应过程中有氧化氮气体逸出,有毒,处理方法参见硝酸钠生产的吸收法。

3.用80kg洁净的蒸馏水在搅拌、加热条件下溶解60kg工业硝酸铅,待溶液沸腾后加入投料量0.5%的化学纯氨水,待氢氧化铁沉淀生成后,趁热过滤,滤液冷却结晶,过滤,离心甩干,即得试剂硝酸铅。一次结晶不合格,可再行重结晶处理。

4.将颗粒状铅溶解于密度为1.40的硝酸中(1kg铅用1250ml硝酸),按反应的速度调节反应温度:

待反应结束后,冷却,硝酸铅即以细小的结晶粉末析出,然后用浓硝酸洗涤,抽滤后按方法3提纯。若采用高纯度铅、硝酸和电导水,可制得高纯硝酸铅。

用途简介

用作玻璃和搪瓷用的奶黄色素原料、纸张的黄色素原料。无机工业用于制造其他铅盐。医药工业用于制造收敛剂。用作相片增感剂。作矿石浮选剂。还用于制造火柴、烟火、炸药的氧化剂。用于镀铬电解液中作为添加剂,也可用作铝合金化学抛光的添加剂。用作分析试剂,氧化剂、照相增感剂。用于铅盐、烟花等的制造,用作媒染剂。

用途

1.用作玻璃和搪瓷用的奶黄色素原料、纸张的黄色素原料。无机工业用于制造其他铅盐。医药工业用于制造收敛剂。

2.用作相片增感剂。作矿石浮选剂。还用于制造火柴、烟火、炸药的氧化剂。

3.用于镀铬电解液中作为添加剂,也可用作铝合金化学抛光的添加剂。

4.用作分析试剂,氧化剂、照相增感剂。

5.用于铅盐、烟花等的制造,用作媒染剂。[18]

硝酸铅 物化性质

外观与性状:
白色晶体
密度:
1.00 g/mL at 20 °C
熔点:
470 °C (dec.)(lit.)
沸点:
83ºC at 760 mmHg
水溶解性:
343 g/L
蒸汽压:
49.8mmHg at 25°C
存储条件/存储方法:
库房通风低温干燥,轻装轻卸,与有机物、还原剂、硫、磷易燃物分开存放
稳定性相关:

1.将1g硝酸铅溶于2mL冷水、0.75mL沸水,溶于2500mL无水乙醇,75mL无水甲醇,不溶于浓硝酸。加热至470℃分解为氧化铅。其溶液呈酸性,25时浓度20%的溶液pH=3.0~4.0。无机氧化剂。遇氧化物立即猛烈反应,着火爆炸。与还原剂、有机物、易燃物等混合可形成爆炸性混合物。受高热分解,产生有毒的氮氧化物。

2.干燥的硝酸铅于205~223 ℃分解,潮湿的硝酸铅于100℃时开始分解,先形成碱式硝酸铅Pb(NO3)2·PbO,继续加热则转化为氧化铅。为强氧化剂,与有机物接触能促使其燃烧。

3.稳定性[12]  稳定

4.禁配物[13]  强还原剂、活性金属粉末、易燃或可燃物

5.避免接触的条件[14]  受热

6.聚合危害[15]  不聚合

7.分解产物[16]  氮氧化物

其它信息:

1.性状:白色立方或单斜晶体,硬而发亮。[1]

2.熔点(℃):470(分解)[2]

3.相对密度(水=1):4.53[3]

4.溶解性:易溶于水、液氨,溶于乙醇。[4]

硝酸铅 安全信息

包装等级:
II
风险类别:
5.1
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R20/22;R33;R50/53;R61;R62;R8
安全说明:
S53-S45-S60-S61-S17-S26-S36/37
RTECS号:
OG2100000
安全标志:
S45:出现意外或者感到不适,立刻到医生那里寻求帮助(最好带去产品容器标签)。
S53:避免暴露——使用前先阅读专门的说明。
S60:本物质残余物和容器必须作为危险废物处理。
S61:避免排放到环境中。参考专门的说明/安全数据表。
危险标志:
T:Toxic

硝酸铅 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
OG2100000
CAS REGISTRY NUMBER :
10099-74-8
LAST UPDATED :
199806
DATA ITEMS CITED :
64
MOLECULAR FORMULA :
N2-O6.Pb
MOLECULAR WEIGHT :
331.21
WISWESSER LINE NOTATION :
PB N-O3*2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
270 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
93 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3613 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
74 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Blood - pigmented or nucleated red blood cells Nutritional and Gross Metabolic - body temperature decrease
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1200 mg/kg/60D-I
TOXIC EFFECTS :
Blood - other changes
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
7 gm/kg/7D-I
TOXIC EFFECTS :
Blood - pigmented or nucleated red blood cells Blood - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - dehydrogenases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
97 mg/kg/27D-C
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other Enzymes
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - duck
DOSE/DURATION :
43 mg/kg/12W-C
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other Enzymes
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
13 gm/kg
SEX/DURATION :
male 6 week(s) pre-mating female 6 week(s) pre-mating - 3 week(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
27 gm/kg
SEX/DURATION :
male 6 week(s) pre-mating female 6 week(s) pre-mating - 3 week(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
43 mg/kg
SEX/DURATION :
female 1-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
36 mg/kg
SEX/DURATION :
male 10 day(s) pre-mating female 10 day(s) pre-mating - 16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
50 mg/kg
SEX/DURATION :
female 3 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
7993 ug/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord) Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
39964 ug/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4) Reproductive - Effects on Newborn - behavioral
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - urogenital system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intratesticular
DOSE :
6624 ug/kg
SEX/DURATION :
male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - testes, epididymis, sperm duct
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
6624 ug/kg
SEX/DURATION :
male 30 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - testes, epididymis, sperm duct
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
100 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
50 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - urogenital system Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
50 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
50 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system Reproductive - Specific Developmental Abnormalities - homeostasis Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Sister chromatid exchange
TYPE OF TEST :
Sister chromatid exchange

MUTATION DATA

TYPE OF TEST :
Sister chromatid exchange
TEST SYSTEM :
Rodent - hamster Ovary
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year: 23,143,1994 *** REVIEWS *** ACGIH TLV-TWA 0.05 mg(Pb)/m3; animal carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 23,325,1980 TOXICOLOGY REVIEW 85DHAX "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Volume(issue)/page/year: Pb,254,1972 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 0.05 mg(Pb)/m3 JAN 1993 OEL-AUSTRALIA:TWA 0.15 mg(Pb)/m3 JAN 1993 OEL-AUSTRIA:TWA 0.1 mg(Pb)/m3 JAN 1993 OEL-BELGIUM:TWA 0.15 mg(Pb)/m3 JAN 1993 OEL-DENMARK:TWA 0.1 mg(Pb)/m3 JAN 1993 OEL-FINLAND:TWA 0.1 mg(Pb)/m3 JAN 1993 OEL-FRANCE:TWA 0.15 mg(Pb)/m3 JAN 1993 OEL-GERMANY:TWA 0.1 mg(Pb)/m3 JAN 1993 OEL-HUNGARY:STEL 0.04 mg(Pb)/m3;Carcinogen JAN 1993 OEL-THE PHILIPPINES:TWA 0.15 mg(Pb)/m3 JAN 1993 OEL-RUSSIA:STEL 0.005 ppm (0.01 mg(Pb)/m3) JAN 1993 OEL-SWEDEN:TWA 0.05 mg(Pb)/m3 (resp. dust) JAN 1993 OEL-SWEDEN:TWA 0.1 mg(Pb)/m3 (total dust) JAN 1993 OEL-SWITZERLAND:TWA 0.1 mg(Pb)/m3 JAN 1993 OEL-THAILAND:TWA 0.2 mg(Pb)/m3 JAN 1993 OEL-TURKEY:TWA 0.2 mg(Pb)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 0.15 mg(Pb)/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO LEAD, INORGANIC-air:10H TWA <0.1 mg(Pb)/m3 REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84473 No. of Facilities: 112 (estimated) No. of Industries: 4 No. of Occupations: 5 No. of Employees: 420 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84473 No. of Facilities: 450 (estimated) No. of Industries: 18 No. of Occupations: 20 No. of Employees: 11440 (estimated) No. of Female Employees: 4246 (estimated)
毒理学数据:

1.急性毒性[5]  LD50:93mg/kg(大鼠静脉);74mg/kg(小鼠腹腔)

2.刺激性  暂无资料

3.亚急性与慢性毒性[6]  实验动物给予硝酸铅可见神经组织明显损伤;血液系统损害。

4.致突变性[7]  吞噬抑制能力:大肠杆菌320μmol/L。体细胞突变:小鼠淋巴细胞450mg/L。

5.致畸性[8]  雌性仓鼠孕后8d静脉内给药最低中毒剂量50mg/kg,导致心血管系统、中枢神经系统、泌尿生殖系统发育畸形。

6.致癌性[9]  IARC致癌性评论:IARC将铅的无机化合物列为G2A,可能人类致癌物。

7.其他[10]  大鼠静脉注射最低中毒剂量(TDLo):25mg/kg(孕9d),对胚胎外结构(如胎盘、脐带)有影响,体壁发育异常,骨骼肌肉发育异常。小鼠皮下注射最低中毒剂量(TDLo):6624μg/kg(30d,雄),致睾丸、附睾和输精管影响。

生态数据:

1.生态毒性  暂无资料

2.生物降解性  暂无资料

3.非生物降解性  暂无资料

4.其他有害作用[11]  该物质对环境有危害,应特别注意对水体的污染;铅元素在生物体内有很强的蓄积作用。

 

硝酸铅 MSDS

第一部分:化学品名称

硝酸铅 分子结构与计算化学数据

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:0

3.氢键受体数量:6

4.可旋转化学键数量:0

5.互变异构体数量:无

6.拓扑分子极性表面积126

7.重原子数量:9

8.表面电荷:0

9.复杂度:18.8

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:3

硝酸铅 表征图谱

推荐供应商更多供应商>>

QQ: 2241752642
微信二维码
电话: 19906633110